Clinical Trial Update: Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of OBE2109 in women with heavy menstrual bleeding due to uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• OBE2109

Snippet

Sponsor: ObsEva SA | Conditions: Uterine Fibroids, Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED